BRXCX
Price
$20.19
Change
+$0.09 (+0.45%)
Updated
Aug 25 closing price
Net Assets
6.09B
MDIHX
Price
$30.99
Change
-$0.10 (-0.32%)
Updated
Aug 24 closing price
Net Assets
44.49B
Interact to see
Advertisement

BRXCX vs MDIHX

BRXCX vs MDIHX Comparison Chart in %
View a ticker or compare two or three
VS
BRXCX vs. MDIHX commentary
Aug 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRXCX is a Buy and MDIHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MDIHX has more cash in the bank: 44.5B vs. BRXCX (6.09B). MDIHX pays higher dividends than BRXCX: MDIHX (1.83) vs BRXCX (0.89). BRXCX was incepted earlier than MDIHX: BRXCX (11 years) vs MDIHX (21 years). BRXCX (1.53) is less costly to investors than MDIHX (1.10). BRXCX is a more actively managed with annual turnover of: 48.00 vs. MDIHX (2.00). MDIHX has a lower initial minimum investment than BRXCX: MDIHX (0) vs BRXCX (1000). BRXCX annual gain was more profitable for investors over the last year : 27.34 vs. MDIHX (16.25). BRXCX return over 5 years is better than : 60.96 vs. MDIHX (33.65).
BRXCXMDIHXBRXCX / MDIHX
Total Expense Ratio1.521.08141%
Annual Report Gross Expense Ratio1.531.10139%
Fund Existence11 years21 years-
Gain YTD18.79414.228132%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.09B44.5B14%
Annual Yield % from dividends0.891.8349%
Returns for 1 year27.3416.25168%
Returns for 3 years87.4855.59157%
Returns for 5 years60.9633.65181%
Returns for 10 years132.62125.19106%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPHA2.270.05
+2.25%
Innate Pharma SA
BN42.120.15
+0.36%
Brookfield Corporation
ABCB85.54-0.41
-0.48%
Ameris Bancorp
CLBK11.65-0.13
-1.15%
Columbia Financial
BTLN0.94-0.01
-1.30%
Brightline Interactive Inc